Long-Term Follow Up with Regard to Potential Immunogenicity: Clinical Experience with NovoSeven® (Recombinant Factor VIla)
2013 ◽
Vol 52
(11)
◽
pp. 1308-1318
◽
Keyword(s):
2018 ◽
Vol 58
(1)
◽
pp. 114-125
◽
Keyword(s):
2000 ◽
Vol 53
(2)
◽
pp. 249
◽
Keyword(s):